Growth Fund Investment Spotlight: Capital Rx
AVTV features Capital Rx, the fastest-growing pharmacy benefits management platform in America
AVTV features Capital Rx, the fastest-growing pharmacy benefits management platform (PBM) in America. Capital Rx is a past investment in our Growth Fund, which offers existing AV investors a portfolio of exclusively follow-on investments with growth potential.
Hear from Matt Gibbs, President of online, cloud-native, pharmacy benefits management platform Capital Rx. In this video, Matt shares what motivated him to join Capital Rx, the company’s distinct business model, plans for the future, and more.
See video policy below.
Estimated View Time: ~3 Minutes
Reserve Your Spot in Growth Fund 3
Investors in our Growth Fund will own a diversified portfolio of follow-on investments in companies indicating promise.
Growth Funds 1 and 2 drew strong investor interest, with hundreds of AV investors having already added the Growth Fund to their portfolio.
If you’re interested, we recommend you log in to our portal and secure your spot promptly by e-signing your Subscription Agreement.
Max Accredited investor limit: 249
Deadline to Join: October 31, 2023
About Capital Rx
Capital Rx is the pharmaceutical industry’s first online, cloud-native PBM to connect buyers (employers and health plans) with drugmakers. The company’s online platform provides price transparency and operational efficiency through services like formulary management, prescription claims processing, and clinical utilization programs. Their ethical framework removes the artificial wall between pharmacies and plan sponsors, saving their clients 27% on average. Read More »
How We’re Involved
- $50 million Series B in 2021 alongside Transformation Capital and Edison Partners
- $106 million Series C in 2022 alongside B Capital and General Catalyst
AV Funds invested in Capital Rx:
- 116 Street Ventures (for the Columbia community)
- Castor Ventures (for the MIT community)
- Lakeshore Ventures (for the University of Chicago community)
- Westwood Ventures (for the UCLA community)
- Growth Fund (follow-ons in highly promising AV investments)
- Total Access Fund (AV’s broadest, most diversified fund)
Contact [email protected] for additional information. To see additional risk factors and investment considerations, visit av-funds.com/disclosures.